4 June 2019 - It is increasingly important that regulatory agencies catalyse the translation of scientific and technological innovation into improved patient-centred health care. 

This commentary highlights the strategic goals of the European Medicines Agency to advance regulatory science and optimize the opportunities arising in areas such as cell and gene therapies, big data and artificial intelligence.

Read Nature Reviews Drug Discovery Commentary